Robert A. Mullinax

Statistics

Publications

Citations

2.3K

H-Index

Active since

2000

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Harvard University

Beth Israel Deaconess Medical Center

Robert A. Mullinax is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and cancer pharmacology.

Publications per year

2000–2021

Publications

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 951 citations · Full text

Medicine, Cancer Biology, Oncology +14

Subgroup of Reproductive Functions of Progesterone Mediated by Progesterone Receptor-B Isoform

Biserka Mulac‐Jeričević, Robert A. Mullinax, Francesco J. DeMayo et al. · Science · 2000 · 703 citations

Life Sciences, Endocrinology, Molecular Biology +14

Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer

Yonathan Lissanu Deribe, Yuting Sun, Christopher Terranova et al. · Nature Medicine · 2018 · 277 citations · Full text

Medicine, Molecular Biology, Oncology +12

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

Yuting Sun, Brooke A. Meyers, Barbara Czakó et al. · Cancer Research · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

Michael Soth, Kang Le, Maria Emilia Di Francesco et al. · Journal of Medicinal Chemistry · 2020 · 91 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

1–5 of 9